|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
We compared Scoliosis Research Society-22r (SRS-22r) and Oswestry Disability Index (ODI) scores using various X-ray parameters at these time points: preoperative period and postoperative 2 years.
|
31389866 |
2020 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
In adult spinal deformity (ASD), the disease-specific Scoliosis Research Society-22r (SRS-22r) tool assesses outcomes.
|
31525469 |
2020 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
To calculate MCID and minimum detectable change (MDC) values of total scores of the Core Outcome Measures Index (COMI), Oswestry Disability Index (ODI), Physical Component Summary (PCS), Mental Component Summary (MCS) of the Short Form 36 (SF-36), and Scoliosis Research Society 22R (SRS-22R) in surgically and nonsurgically treated ASD patients who have completed an anchor question at pretreatment and 1-year follow-up.
|
30010046 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The refined 22-item Scoliosis Research Society (SRS-22r) questionnaire was recorded.
|
31674249 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
When compared with females, males with idiopathic scoliosis tend to have slightly higher scores in the scoliosis specific SRS-22r but not in the generic quality of life measurement EQ-5D.
|
30180148 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
Scores on the Scoliosis Research Society Questionnaire (SRS-24) were catalogued and evaluated.
|
31045663 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Patients were 40- to 80-years-old with ASLS, defined as lumbar coronal Cobb ≥30° and Oswestry Disability Index (ODI) ≥20 or Scoliosis Research Society-22 (SRS-22) ≤4.0 in pain, function, and/or self-image domains.
|
30921297 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Determine the range of pediatric Patient-Reported Outcomes Measurement Information System (PROMIS) scores for patients treated for adolescent idiopathic scoliosis (AIS) and assess correlation with Scoliosis Research Society-22 (SRS-22) domain scores.
|
31574066 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Radiographic parameters obtained by whole-spine standing x-ray, the Oswestry Disability Index (ODI), and Scoliosis Research Society-22 (SRS-22) questionnaire were assessed.
|
30234799 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Clinical outcome was assessed using Scoliosis Research Society-22 patient questionnaire (SRS-22r) scores and a visual analog scale for low back pain before and at 2 years postoperatively.
|
31361270 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Before surgery, Groups STK and STLK were comparable in terms of age, gender, body mass index, fusion levels, follow-up time, some radiographic parameters and the 22-item Scoliosis Research Society questionnaire (SRS-22) evaluation.
|
30986575 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
PROMIS has shorter completion time and greater research flexibility for the heterogeneous adult spinal deformity (ASD) population versus the Oswestry Disability Index (ODI) and Scoliosis Research Society 22-item questionnaire (SRS-22r).
|
30053523 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The Scoliosis Research Society-22R (SRS-22R), an HRQL instrument for spinal deformity, provides summary scores spanning several health domains, but these may be difficult for patients to utilize in planning their specific care goals.
|
31325052 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Prospective multicenter study of the changes in Scoliosis Research Society Outcome Questionaire 22 (SRS-22) scores for 78 patients younger than 25 years old surgically treated for lumbosacral spondylolisthesis OBJECTIVE.
|
30005048 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The applicability of the Scoliosis Research Society (SRS-30) questionnaire has not been tested in relation to different pain origins.
|
31106613 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The purpose of this study was to determine the MDMD for the Scoliosis Research Society-22r (SRS-22r) in adolescent idiopathic scoliosis (AIS) patients treated with surgery.
|
30986576 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, each TBSA parameter was correlated to patient-reported outcome (PRO) scores using the Oswestry Disability Index (ODI) and Scoliosis Research Society-22 (SRS-22) instruments.
|
31125961 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The outcome measures included PFA and QoL scores measured from the Scoliosis Research Society SRS-30 QoL questionnaire.
|
30296577 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
One hundred three parents completed the Adapted Dutch EOSQ-24, the Child Health Questionnaire (CHQ-28 PF), and the Scoliosis Research Society Questionnaire (SRS-22r).
|
31374000 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The mean values of the Scoliosis Research Society 22 (SRS-22) questionnaire in Lenke 5C was 92 ± 9 (71-109) and in Lenke 6C 90.3 ± 9 (75-107).
|
30896585 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The demographics, complications, health-related quality of life (HRQOL) subdomains, and radiographic parameters were examined to determine their correlation coefficients with the Scoliosis Research Society-22 questionnaire (SRS-22R) satisfaction scores at 2 years (Sat-2y score).
|
31075761 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
OBJECTIVEAfter using PROsetta Stone crosswalk tables to calculate Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) and Pain Interference (PI) scores, the authors sought to examine 1) correlations with Scoliosis Research Society-22r (SRS-22r) scores, 2) responsiveness to change, and 3) the relationship between baseline scores and 2-year follow-up scores in adult spinal deformity (ASD).METHODSPROsetta Stone crosswalk tables were used to converted SF-36 scores to PROMIS scores for pain and physical function in a cohort of ASD patients with 2-year follow-up.
|
30797200 |
2019 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Scoliosis Research Society-22r (SRS-22r) has been shown to be reliable, valid and responsive to change in patients with adult spinal deformity (ASD) undergoing surgery.
|
28988878 |
2018 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
The purpose was to evaluate the impact of serious adverse events (SAEs) on patient-reported outcomes (PROs) in nonoperative management of ASLS as measured by Scoliosis Research Society-22 (SRS-22), Oswestry Disability Index (ODI), and Short Form-12 (SF-12) at 2-year follow-up.
|
29095407 |
2018 |
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
BEFREE |
Arabic version of the Scoliosis Research Society 22 revision (SRS-22r) questionnaire used to study HRQOL of adolescents with severe untreated CK or CKS in a dev eloping country.
|
29462064 |
2018 |